Abstract
Epstein-Barr virus (EBV) status was retrospectively analysed by the use of EBV-encoded small RNA (EBER) in situ hybridization (ISH) and EBV DNA analysis in whole blood with diffuse large B-cell lymphoma, to assess the clinical significance for diagnosis, prognostication, and monitoring of tumour burden. Three hundred and twenty-nine patients were retrospectively enrolled, with 232 patients being available for EBER ISH analysis, 189 patients for EBV DNA analysis, and 138 patients for both analyses. EBER was positive in 24 (10.3%) patients, and EBV DNA was positive in 18 (9.5%) patients; the two analyses had 92.8% concordance. Patients with pretreatment EBER positivity had worse overall survival (OS) than those without EBER positivity (p 0.03); the same pattern was observed for EBV DNA (p < 0.01). A significant p-value was also observed for OS when EBER and EBV DNA were combined (p < 0.01). On multivariate analysis, both EBV DNA (hazard ratio 3.71, 95% CI 1.78-7.74, p < 0.01) and EBER (hazard ratio 2.03, 95% CI 1.03-4.00, p 0.04) remained independent predictive factors for OS. Regarding the dynamic changes in copy number of elevated EBV DNA, the transformation from positive to negative after cycle 3 with chemotherapy may have the...Continue Reading
References
Oct 17, 1985·Nature·C M RooneyA B Rickinson
Nov 25, 2000·British Journal of Haematology·K I LeiY M Lo
Dec 21, 2000·Japanese Journal of Cancer Research : Gann·T KuzeM Abe
May 1, 1965·The Journal of Experimental Medicine·M A EPSTEINY M BARR
Mar 27, 2004·The New England Journal of Medicine·David A Thorley-Lawson, Andrew Gross
Aug 21, 2004·Clinical Chemistry·Lydia C W LitY M Dennis Lo
Apr 3, 2007·Blood·Sarah ParkWon Seog Kim
Sep 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takashi OyamaShigeo Nakamura
May 22, 2008·Reviews in Medical Virology·Hiroshi KimuraYukihiro Nishiyama
Jan 16, 2009·Human Pathology·Sarah E Gibson, Eric D Hsi
Oct 29, 2009·Leukemia & Lymphoma·Domingo MoralesJorge Castillo
Nov 17, 2009·Human Pathology·Sylvia HoellerStephan Dirnhofer
Feb 16, 2010·International Journal of Hematology·Shih-Sung ChuangShu-Hui Lin
Dec 25, 2010·Journal of Medical Virology·Naoki WadaKatsuyuki Aozasa
Oct 11, 2011·Blood·Ritsuro SuzukiUNKNOWN NK-cell Tumor Study Group
Dec 14, 2011·Hematology·Elaine S Jaffe, Stefania Pittaluga
Jul 27, 2012·Leukemia & Lymphoma·Yi PanKai Fu
Jan 25, 2013·Blood·Shimin HuKen H Young
Feb 7, 2013·Blood·Jennifer A KanakryRichard F Ambinder
Sep 5, 2013·JAMA : the Journal of the American Medical Association
Nov 13, 2013·Journal of Clinical Pathology·Sheng-Tsung ChangShih-Sung Chuang
Citations
Sep 10, 2015·Cancer Science·Akinao OkamotoNobuhiko Emi
Jul 7, 2015·Journal of Hematopathology·J Han van Krieken
Mar 18, 2017·Leukemia & Lymphoma·Yi ChenJianda Hu
Mar 10, 2018·Pathogens·Stefan D DojcinovLeticia Quintanilla-Martinez
Jun 15, 2018·Hematological Oncology·Shuchao QinJianyong Li
Apr 7, 2018·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jin-Hua LiangWei Xu
Jun 28, 2019·Internal Medicine·Shin LeeTakahiro Yamauchi
Nov 6, 2015·Oncotarget·Jin-Hua LiangWei Xu
Jun 20, 2018·PloS One·Xiaojuan GaoBaohong Yue
May 7, 2021·Leukemia Research·Jia-Qi QinWei Xu
Aug 25, 2021·Blood Advances·Estelle BourbonClémentine Sarkozy
Sep 15, 2021·International Journal of Cancer. Journal International Du Cancer·Ziyuan ShenUNKNOWN Huaihai Lymphoma Working Group (HHLWG)